Insulet (PODD) Tops Q2 EPS by 9c, Lifts Revenue Guidance
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $142.28 -3.53%
EPS Growth %: +28.2%
Financial Fact:
Gross profit: 55.64M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +28.2%
Financial Fact:
Gross profit: 55.64M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q2 EPS of ($0.08), $0.09 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $87.3 million versus the consensus estimate of $81.1 million.
GUIDANCE:
Insulet sees Q3 2016 revenue of $88-91 million, versus the consensus of $87 million.
Insulet sees FY2016 revenue of $345-355 million, versus the consensus of $343.6 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- BMO Capital Starts Lululemon (LULU) at Underperform
- GameStop beats second quarter estimates on collectibles
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
